Meeting
2022 ASCO Quality Care Symposium
VOCAL (Views of Ovarian Cancer patients-how maintenance therapy Affects their Lives) study: A lens into the financial and quality of life (QoL) impact of disease burden and ethnic disparities reported directly by the patient.
Authors
Dana Meredith Chase
Creighton University Phoenix School of Medicine, Tempe, AZ
Dana Meredith Chase, Soham Shukla, Joanna de Courcy, Hilary Ellis, James Piercy, Teresa Taylor-Whiteley, Amanda Golembesky, Stephanie L. Wethington
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Integrating Patient Experience Assessment and Patient Reported Outcomes Into Practice
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 274)
DOI
10.1200/JCO.2022.40.28_suppl.274
Abstract #
274
Poster Bd #
G13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Effectiveness of PARP inhibitor maintenance therapy (mPARPi) in advanced ovarian cancer (OC) by BRCA1/2 and HRD signature in real-world practice.
First Author: Debra L. Richardson
Poster
2022 ASCO Annual Meeting
Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644).
First Author: Jean Emmanuel Kurtz
Poster
2019 ASCO Annual Meeting
Recurrence of ovarian cancer in BRCAwt patients without maintenance therapy: Real-world evidence.
First Author: Melinda Louie-Gao
Poster
2019 ASCO Annual Meeting
Real-world data analysis of ovarian cancer (OC) maintenance utilization among maintenance eligible patients.
First Author: David Garofalo